Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Classification and identifiers
- Solicitation number
- FOR-HG-25-020
- Assistance listing (CFDA)
- 93.172
Amount
Amount not published by the funder
Who can apply
Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply; Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply; Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this opportunity
The National Human Genome Research Institute (NHGRI) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications to study the effects of genetic or environmental interactions on genomic variant impact. To accomplish this, centers funded through this initiative will propose a research framework to investigate whether interactions, with effects beyond additive, are important modifiers of the impact of variants. Centers will apply their framework to experimentally test combinations for interactions. The rationale for this research is the identification of a structure within the interaction landscape might result in better predictions of the most important interactions to test, leading to more effective variant testing, better understanding ...
Related opportunities
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)National Institutes of Health
- Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)National Institutes of Health
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)National Institutes of HealthCloses Nov 2026Up to $300K
- Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)National Institutes of Health
- Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)National Institutes of Health
- Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2028